Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Natco Pharma Limited
NATCOPHARMCurrent price
1 376.55 INR
+3.55 INR (+0.26%)
Last closed
1 366.95 INR
Company
www.natcopharma.co.in
ISIN
INE987B01026
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
246 553 886 751 INR
Yield for 12 month
+0.65 %
1Y
3Y
5Y
10Y
15Y
NATCOPHARM
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. Address: Natco House, Hyderabad, India, 500034
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
113 397.63 INRP/E ratio
12.6742Dividend Yield
0.4 %Current Year
+40 019 999 988 INR
Last Year
+27 070 999 964 INR
Current Quarter
+13 625 999 977 INR
Last Quarter
+10 682 999 964 INR
Current Year
+25 736 000 008 INR
Last Year
+20 797 999 966 INR
Current Quarter
+9 962 999 977 INR
Last Quarter
+7 277 000 009 INR
Key Figures NATCOPHARM
1 year
3 years
5 years
10 years
EBITDA
23 736 999 923 INR
Operating Margin TTM
PE Ratio
12.6742
Return On Assets TTM
18.89 %
PEG Ratio
–
Return On Equity TTM
31.23 %
Wall Street Target Price
113 397.63 INR
Revenue TTM
45 638 000 640 INR
Book Value
399.14 INR
Revenue Per Share TTM
Dividend Share
1.25 INR
Quarterly Revenue Growth YOY
32.9 %
Dividend Yield
0.4 %
Gross Profit TTM
20 541 000 000 INR
Earnings per share
108.61 INR
Diluted Eps TTM
108.61 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
83.5 %
Profit Margin
42.61 %
Dividend Analytics NATCOPHARM
Dividend growth over 5 years
12 %Continuous growth
2 yearsPayout Ratio 5 years average
32 %Dividend History NATCOPHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
5.75
Ex Dividend Date
25.11.2024
Forward Annual Dividend Yield
0.42 %
Last Split Factor
5:1
Payout Ratio
5.07 %
Last Split Date
26.11.2015
Dividend Date
–
Stock Valuation NATCOPHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
12.6742
Forward PE
16.8634
Enterprise Value Revenue
5.809
Price Sales TTM
5.4024
Enterprise Value EBITDA
12.3447
Price Book MRQ
4.183
Financials NATCOPHARM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NATCOPHARM
For 52 weeks
750.08 INR
1 639 INR
50 Day MA
1 429.04 INR
Shares Short Prior Month
–
200 Day MA
1 207.36 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart